Stuart Singer
Papers
1
Total Citations
2
H-Index
1
About
Stuart Singer is a clinical researcher whose work centers on optimizing treatment strategies for head and neck cancers, with a particular focus on balancing oncologic efficacy with functional preservation. His major contribution lies in the design and leadership of a pivotal Phase III study comparing the “best of” radiotherapy against the “best of” trans-oral surgery (TOS) for patients with early-stage oropharyngeal, supraglottic, and hypopharyngeal carcinomas. This trial addresses a critical, long-standing clinical equipoise: whether modern radiotherapy or minimally invasive surgical approaches yield superior outcomes for T1-T2, N0-N1 tumors. By directly comparing these modalities, Singer’s work aims to provide definitive evidence to guide personalized treatment decisions, potentially reducing overtreatment and improving quality of life. While his most cited paper has garnered 2 citations to date, its significance lies in its potential to reshape standard-of-care protocols. Singer’s research is particularly notable for its patient-centered design, emphasizing functional outcomes alongside survival. His work represents a meaningful step toward de-escalation strategies in head and neck oncology, offering a framework for future trials that prioritize both cure and patient well-being.
Research Focus
Key Achievements
Top Papers
- 1